Halloran PF - Search Results

1

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study.

Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Gauthier P, Billings P, Lawrence C, Lowe D, Hidalgo LG; the Trifecta Investigators. Halloran PF, et al. Transplantation. 2023 Mar 1;107(3):709-719. doi: 10.1097/TP.0000000000004324. Epub 2023 Feb 21. Transplantation. 2023. PMID: 36190186 Free PMC article. Clinical Trial.

2

The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.

Halloran PF, Schlaut J, Solez K, Srinivasa NS. Halloran PF, et al. Transplantation. 1992 Mar;53(3):550-5. Transplantation. 1992. PMID: 1549846

3

The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection.

Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. Halloran PF, et al. Transplantation. 1990 Jan;49(1):85-91. doi: 10.1097/00007890-199001000-00019. Transplantation. 1990. PMID: 2301035

4

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.

Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Trpkov K, et al. Among authors: halloran pf. Transplantation. 1996 Jun 15;61(11):1586-92. doi: 10.1097/00007890-199606150-00007. Transplantation. 1996. PMID: 8669102

5

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Halloran P, et al. Transplantation. 1997 Jan 15;63(1):39-47. doi: 10.1097/00007890-199701150-00008. Transplantation. 1997. PMID: 9000658 Clinical Trial.

6

Microchimerism in sensitized renal patients.

Inman B, Halloran B, Melk A, Ramassar V, Halloran PF. Inman B, et al. Among authors: halloran pf, halloran b. Transplantation. 1999 May 27;67(10):1381-3. doi: 10.1097/00007890-199905270-00018. Transplantation. 1999. PMID: 10360597

7

Role of IFN-gamma in allograft rejection.

Hidalgo LG, Halloran PF. Hidalgo LG, et al. Among authors: halloran pf. Crit Rev Immunol. 2002;22(4):317-49. Crit Rev Immunol. 2002. PMID: 12678431 Review.

8

The role of B cells and alloantibody in the host response to human organ allografts.

Vongwiwatana A, Tasanarong A, Hidalgo LG, Halloran PF. Vongwiwatana A, et al. Among authors: halloran pf. Immunol Rev. 2003 Dec;196:197-218. doi: 10.1046/j.1600-065x.2003.00093.x. Immunol Rev. 2003. PMID: 14617206 Review.

9

Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice.

Jabs WJ, Sedlmeyer A, Ramassar V, Hidalgo LG, Urmson J, Afrouzian M, Zhu LF, Halloran PF. Jabs WJ, et al. Among authors: halloran pf. Am J Transplant. 2003 Dec;3(12):1501-9. doi: 10.1046/j.1600-6135.2003.00269.x. Am J Transplant. 2003. PMID: 14629280 Free article.

10

Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B.

Halloran PF, Urmson J, Ramassar V, Melk A, Zhu LF, Halloran BP, Bleackley RC. Halloran PF, et al. Among authors: halloran bp. Am J Transplant. 2004 May;4(5):705-12. doi: 10.1111/j.1600-6143.2004.00421.x. Am J Transplant. 2004. PMID: 15084164 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters